Physician profile
Greg Smart
NPI 1073506010
$256.86
in general payments reported to CMS, 2019-2025
8 companies · $30.95 in 2025
The $30.95 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.41 · 2020: $65.21 · 2021: $17.26 · 2022: $40.86 · 2023: $30.08 · 2024: $59.09 · 2025: $30.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $62.68 | 2020-2025 | Farxiga |
| Novo Nordisk INC | $41.50 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $36.08 | 2020-2024 | Mounjaro |
| Abbvie INC. | $33.77 | 2021-2023 | Vraylar |
| Abbott Laboratories | $28.40 | 2023-2024 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $27.68 | 2024 | |
| Amgen INC. | $13.80 | 2022 | |
| Glaxosmithkline, LLC. | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Smart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.